Developments include low-dose atropine eye drops and LASIK procedures. The global myopia and presbyopia treatment market is ...

The FDA has approved the first and so far only pharmacological treatment for presbyopia, a sight condition that typically starts in middle age and involves difficulty in focusing on near objects ...

The company sees AGN-190584 as being a first-line treatment for people newly-diagnosed with mild-to-moderate presbyopia, or as an adjunct to reading glasses for people who want more flexibility in ...

Presbyopia is a common age-related condition that affects the ability to see close objects clearly, often requiring individuals to use reading glasses. Corneal inlays have emerged as a potential ...

To improve patient satisfaction with premium IOLs, surgeons must address five key areas of cataract surgery, according to a ...

DelveInsight's“Presbyopia Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Presbyopia, historical and forecasted epidemiology as well as the ...

The global market for myopia and presbyopia treatment has witnessed significant momentum, driven by increasing cases of vision impairment and the growing prevalence of age-related eye conditions. With ...

It offers eye drop product treatment for presbyopia. The company was founded by James McCollum in July 2013 and is headquartered in Solana Beach, CA.